CLASS III Drug recall · Reported 19 Apr 2017 · FDA Enforcement Report

Fluocinolone Acetonide Topical Solution USP 01% For Topical recalled

Novel Laboratories is recalling Fluocinolone Acetonide Topical Solution USP 01% For Topical Use Only, Not for Ophthalmic, distributed nationwide in the US. The recall was initiated on 22 Feb 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # M15496; Exp. 10/17 Lot # M15507; Exp. 12/17
NDC43386-069
UPC0343386069606
Quantity recalled7,656 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0653-2017
FDA event ID
76231
Recalling firm
Novel Laboratories, Somerset, NJ
Manufacturer
Lupin Pharmaceuticals,Inc.
Classification
Class III
Status
Terminated
Recall initiated
22 Feb 2017
FDA classified
11 Apr 2017
Reported
19 Apr 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Eye Drops

Timeline

22 Feb 2017Recall initiated by company
11 Apr 2017Classified by FDA+48 days
19 Apr 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Chemical Contamination

Product as listed by the FDA

Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use Only, Not for Ophthalmic Use, 60 mL bottle, Rx Only, Manufactured for Gavis Pharmaceuticals, LLC, Somerset NJ 08873, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873, NDC 43386-069-60

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is Fluocinolone Acetonide Topical Solution USP 01% For Topical Use Only, Not for Ophthalmic recalled?

Yes. Novel Laboratories recalled Fluocinolone Acetonide Topical Solution USP 01% For Topical Use Only, Not for Ophthalmic on 22 Feb 2017. The recall is Class III and its status is Terminated. Recall number D-0653-2017.

Why was it recalled?

Chemical Contamination

Which lots are affected?

Lot # M15496; Exp. 10/17 Lot # M15507; Exp. 12/17

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Novel Laboratories

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIILupin Hydrocodone Bitartrate recalled by Novel LaboratoriesHydrocodone Bitartrate And Homatropine MethylbromideNovel LaboratoriesPotency & AssayNationwide
DrugCLASS IIIFamotidine for Oral Suspension, USP 40 mg recalled by Novel LaboratoriesFamotidineNovel LaboratoriesPotency & AssayNationwide

Other Fluocinolone Acetonide recalls

All 13